Grant: Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Université de Montréal
$113,250.00
The roles of MBNL proteins in the pathogenesis of myotonic dystrophy
EF 2012-13
Résumé
Myotonic dystrophy type 1 (DM1) is caused by an expansion of CUG-triplet repeats in the DMPK mRNA. The RNA-binding protein Muscleblind-like 1 (MBNL1) binds the UGCU motif in RNA and it is involved in the aggregation of mutant CUG-repeat RNA into nuclear foci. MBNL1 also has several normal functions in the cell; as an alternative splicing factor, and as a regulator of the cytoplasmic localization of mRNA. Non-disease mRNA bound by MBNL1 do not form nuclear foci, and it is not understood why MBNL1 causes the nuclear retention and aggregation of CUG-repeat mRNA. In this project, a team of three investigators will use live-cell microscopy, purification of RNA aggregates and biochemical approaches to elucidate the mechanism of MBNL1 and CUG-repeat RNA aggregate formation in DM1, and also define the role of MBNL1 in cytoplasmic mRNA localization. This work will provide important insights into the mechanisms of toxic RNA aggregate formation, the process through which they perturb the functions of MBNL factors, as well as the ensuing impact on the intracellular trafficking of key MBNL1 target mRNAs. Understanding these pathways will allow the development of new drugs to inhibit the nuclear retention of the mutant DMPK mRNA in DM1 patients or that help to restore the normal localization properties of mistargeted cellular mRNAs.
Programme
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
286116
Name
Chartrand Pascal
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Muscular Dystrophy Canada (Toronto, Ontario)
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
The roles of MBNL proteins in the pathogenesis of myotonic dystrophy
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$113,250
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Keyworddelim
Mbnl1; Mrna Localization; Myotonic Dystrophy; Pathogenesis; Rna Aggregation
Abstract
Myotonic dystrophy type 1 (DM1) is caused by an expansion of CUG-triplet repeats in the DMPK mRNA. The RNA-binding protein Muscleblind-like 1 (MBNL1) binds the UGCU motif in RNA and it is involved in the aggregation of mutant CUG-repeat RNA into nuclear foci. MBNL1 also has several normal functions in the cell; as an alternative splicing factor, and as a regulator of the cytoplasmic localization of mRNA. Non-disease mRNA bound by MBNL1 do not form nuclear foci, and it is not understood why MBNL1 causes the nuclear retention and aggregation of CUG-repeat mRNA. In this project, a team of three investigators will use live-cell microscopy, purification of RNA aggregates and biochemical approaches to elucidate the mechanism of MBNL1 and CUG-repeat RNA aggregate formation in DM1, and also define the role of MBNL1 in cytoplasmic mRNA localization. This work will provide important insights into the mechanisms of toxic RNA aggregate formation, the process through which they perturb the functions of MBNL factors, as well as the ensuing impact on the intracellular trafficking of key MBNL1 target mRNAs. Understanding these pathways will allow the development of new drugs to inhibit the nuclear retention of the mutant DMPK mRNA in DM1 patients or that help to restore the normal localization properties of mistargeted cellular mRNAs.
Competitiondate
201303
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chartrand, Pascal
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $113,250~ $0~